Filing Details

Accession Number:
0001209191-11-019004
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2011-03-21 16:36:32
Reporting Period:
2011-03-17
Filing Date:
2011-03-21
Accepted Time:
2011-03-21 16:36:32
Original Submission Date:
2011-03-18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333170 Nxstage Medical Inc. NXTM Electromedical & Electrotherapeutic Apparatus (3845) 043454702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1382096 S. Robert Brown C/O Nxstage Medical, Inc.
439 South Union Street, 5Th Floor
Lawrence MA 01843
Sr. Vice President, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-03-17 15,000 $19.56 59,077 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2010, and amended on September 13, 2010.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.23 to $19.84. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
  3. This amended report amends the reporting person's original Form 4, filed on 03/18/2011. On 03/18/2011, the reporting person filed a Form 4 reporting the acquisition of 15,000 shares of common stock that did not in fact occur. Rather, the reporting person disposed of 15,000 shares of common stock. As of 03/18/2011, the reporting person owned 59,077 shares of common stock.